Business
AGM Post-Meeting Shareholder Engagement Update
Oxford Nanopore Technologies plc has provided an update following its AGM, detailing shareholder engagement regarding Resolution 12. The company has received feedback from major shareholders, which aligns with the Board's focus on maximizing long-term potential and refining strategic planning to prioritize high-priority opportunities. The appointment of Francis Van Parys as Chief Executive Officer is highlighted, bringing experience in scaling life-sciences businesses to lead the commercial strategy and strengthen the management team for future growth and stakeholder value. Disclaimer*
About this update from Oxford Nanopore Technologies Plc
[{"type":"text","content":"\n\nOxford Nanopore Technologies plc\n(\"Oxford Nanopore\" or the \"Company\")\nAGM Post-Meeting Shareholder Engagement Update\n8 December 2025\nIn accordance with Provision 4 of the UK Corporate Governance Code, Oxford Nanopore Technologies plc (LSE: ONT) is providing an update to the statements made on 4 June 2025 in relation to the voting outcome of Resolution 12 at its 2025 Annual General Meeting (\"AGM\").\nFollowing the AGM, the Company has undertaken an engagement exercise and invited feedback from its major shareholders to understand why certain shareholders were unable to support the resolution. The Board is grateful to those shareholders who engaged with this process.\nFeedback received from shareholders has been consistent with the Board's focus on maximising the long-term potential of Oxford Nanopore. As previously announced, the Company continues to refine its strategic planning process to ensure it prioritises and executes on high-priority opportunities that best leverage the unique capabilities of Oxford Nanopore's technology. This will enable the Company to focus resources where it can create the greatest long-term value for stakeholders.\nThe appointment of Francis Van Parys as Chief Executive Officer brings extensive experience in scaling life-sciences businesses. Francis will lead the next phase of the commercial strategy and will work closely with the Board to deepen and strengthen the broader capability set across the management team to support the next phase of growth and deliver long-term value for all stakeholders.\n-ENDS-\nFor further information please contact:\[email protected]\[email protected]\n \nAbout Oxford Nanopore Technologies plc:\nOxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer. Oxford Nanopore's technology also has the potential to provide broad, high impact, rapid insights in a number of areas including healthcare...